Bicycle Therapeutics plc
BCYC
Last
$3.89
Day
+2.1%
1y
-57.0%
5y
-91.4%
52w
-58.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-10-2918d
EMA 21
3.78
EMA 50
3.91
EMA 200
5.00
20d high
-5.7%
5y high
-93.9%
5y range
1th
Positions held
Your positionsBCYC isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-10
Hold
avoid
Signal
Sell
Target
$4.23
Stop
$3.46
Stop distance
11.1%
Target vs last
+8.7%
Fundamentals
| Market cap | $266.67M | Enterprise value | -$228.72M | Trailing P/E | — | Forward P/E | -1.71 |
| PEG | — | Price / book | 0.52 | Beta | 1.68 | Dividend yield | 0.00% |
| Revenue growth | -78.5% | Earnings growth | — | Gross margin | -2.1% | Operating margin | -86.7% |
| Profit margin | 0.0% | ROE | -32.3% | ROA | -17.9% | Debt / equity | 0.03 |
| Current ratio | 12.08 | Free cash flow | -$99.82M | Analyst recommendation | none | Mean target | $9.50 |
| 52w high | $9.10 | 52w low | $3.33 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.6M | $0.9M | $48.0M | $11.7M | $2.9M |
| Op margin | -8684.9% | -7394.5% | -51.4% | -560.0% | -2991.3% |
| Net income | -$50.3M | -$60.8M | -$20.2M | -$59.1M | -$79.0M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$54.6M | -$65.6M | -$24.7M | -$65.7M | -$87.3M |
- Revenue -29% vs prior quarter ($0.6M vs $0.9M).
- Operating margin compressed to -8684.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $72.6M | $35.3M | $27.0M | $14.5M |
| Op margin | -341.3% | -592.9% | -704.1% | -806.6% |
| Net income | -$219M | -$169M | -$181M | -$113M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$248M | -$209M | -$190M | -$117M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsBCYC · daily+5.0% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin